Chefsache Nachhaltigkeit [[electronic resource] ] : Praxisbeispiele aus Unternehmen / / herausgegeben von Peter Buchenau, Monika Geßner, Christian Geßner, Axel Kölle |
Edizione | [1st ed. 2016.] |
Pubbl/distr/stampa | Wiesbaden : , : Springer Fachmedien Wiesbaden : , : Imprint : Springer Gabler, , 2016 |
Descrizione fisica | 1 online resource (327 p.) |
Disciplina | 650 |
Soggetto topico |
Entrepreneurship
Globalization Markets Leadership Emerging Markets/Globalization Business Strategy/Leadership |
ISBN | 3-658-11072-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | ger |
Nota di contenuto | Wirtschaft -- Nachhaltigkeit -- Corporate Social Responsibility. |
Record Nr. | UNINA-9910483036103321 |
Wiesbaden : , : Springer Fachmedien Wiesbaden : , : Imprint : Springer Gabler, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Chemistry entrepreneurship / / edited by Javier García-Martínez and Kunhao Li |
Pubbl/distr/stampa | Weinheim, Germany : , : John Wiley & Sons, , [2022] |
Descrizione fisica | 1 online resource (291 pages) |
Disciplina | 338.4766 |
Soggetto topico |
Chemical industry
Entrepreneurship Chemical workers |
Soggetto genere / forma | Electronic books. |
ISBN |
3-527-81987-8
3-527-81986-X 3-527-81985-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover -- Title Page -- Copyright -- Contents -- Foreword -- Preface -- Chapter 1 We Need An Entrepreneurial Culture in Chemistry: Do You Have What It Takes to be a Chemistry Entrepreneur? -- 1.1 Introduction: Disruptive Innovation in Chemistry is in High Demand -- 1.2 Examples of Innovation in Chemistry Catching the Eye of the Mainstream Market -- 1.2.1 Food and Nutrition -- 1.2.1.1 Just (formerly Hampton Creek) -- 1.2.1.2 Impossible Foods -- 1.2.1.3 Perfect Day -- 1.2.1.4 Endless West (formerly Ava Winery) -- 1.2.2 Sustainable/Renewable Chemistry -- 1.2.2.1 Ginkgo Bioworks -- 1.2.2.2 Modern Meadow -- 1.2.2.3 Genomatica -- 1.2.2.4 Zymergen -- 1.2.3 Biotech/Pharma -- 1.2.3.1 Moderna Therapeutics -- 1.2.3.2 Unity Biotechnology -- 1.2.3.3 CRISPR Therapeutics, Intellia Therapeutics, and Editas Medicine -- 1.2.4 Diagnostics -- 1.2.4.1 23andme -- 1.2.4.2 Grail Diagnostics -- 1.2.4.3 Viome -- 1.2.5 Cautionary Tales -- 1.2.5.1 Theranos -- 1.2.5.2 Solazyme (TerraVia) -- 1.3 Unique Challenges for Chemistry Entrepreneurs -- 1.3.1 The Most Important Trait of Every Chemical Entrepreneur -- 1.3.2 Chemistry Accelerators, Incubators, and Academic Spin‐offs -- 1.3.3 Do Something, do Anything, even if it is Wrong -- 1.3.3.1 Penicillin -- 1.3.3.2 Post‐It -- 1.3.3.3 Saccharin -- 1.3.3.4 Teflon -- 1.3.3.5 Viagra -- 1.3.4 You have your Discovery -- now you need a Patent -- 1.3.4.1 Provisional Patent -- 1.3.4.2 Patent Application -- 1.3.4.3 Patent Prosecution -- 1.3.4.4 Structure of the Patent Claims -- 1.3.4.5 Patent Search and Prior Art -- 1.3.4.6 Publishing Before Patenting -- 1.3.4.7 PCT International Patent -- 1.3.4.8 Protectable Patent Value -- 1.3.4.9 Selecting the Wrong Lawyer for the Job -- 1.4 Invention is Only the Beginning of Creating a Company -- 1.4.1 Know your Role: Founding CEO vs. Founder vs. Inventor.
1.4.2 Raising Money: Acquiring the Right Money at the Right Time -- 1.4.2.1 Self‐funding -- 1.4.2.2 Friends and Family -- 1.4.2.3 Angel Investors -- 1.4.2.4 Accelerators and Incubators -- 1.4.2.5 Debt -- 1.4.2.6 Strategic Investment -- 1.4.2.7 Private Equity -- 1.4.2.8 Venture Capital -- 1.4.2.9 Investment Banks -- 1.4.3 Can you get the idea for Commercialization? -- 1.4.4 When you are Ready to Commercialize, which path do you take? -- 1.4.4.1 Licensing Deal -- 1.4.4.2 Business‐to‐Business (B2B) -- 1.4.4.3 Business‐to‐Consumer (B2C) -- 1.5 Do you have the Traits of an Entrepreneur? -- 1.6 Summary: Do You Have What It Takes? -- Recommended Readings and References -- Author Biography -- Chapter 2 Taking Ideas Out of the Lab: Why and When to Start a Company in the Biomedical Field -- 2.1 Introduction -- 2.2 Company Case Studies: Interviews with the Founding Scientists -- 2.2.1 Advanced Inhalation Research: Interview with David Edwards -- 2.2.1.1 Core Technology -- 2.2.1.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.1.3 Why was it Important to Start Advanced Inhalation Research? -- 2.2.1.4 When was the Technology Ready to Start Advanced Inhalation Research? -- 2.2.1.5 What Lessons Did You Learn Through This Process? -- 2.2.1.6 Current Status -- 2.2.2 Kala Pharmaceuticals: Interview with Justin Hanes -- 2.2.2.1 Core Technology -- 2.2.2.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.2.3 Why was it Important to Start Kala Pharmaceuticals? -- 2.2.2.4 When was the Technology Ready to Start Kala Pharmaceuticals? -- 2.2.2.5 What Lessons Did You Learn Through This Process? -- 2.2.2.6 Current Status -- 2.2.3 Moderna: Interview with Derrick Rossi -- 2.2.3.1 Core Technology -- 2.2.3.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.3.3 Why was it Important to Start Moderna?. 2.2.3.4 When was the Technology Ready to Start Moderna? -- 2.2.3.5 What Lessons Did You Learn Through This Process? -- 2.2.3.6 Current Status -- 2.2.4 Sigilon Therapeutics: Interview with Arturo Vegas -- 2.2.4.1 Core Technology -- 2.2.4.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.4.3 Why was it Important to Start Sigilon? -- 2.2.4.4 When was the Technology Ready to Start Sigilon? -- 2.2.4.5 What Lessons Did You Learn Through This Process? -- 2.2.4.6 Current Status -- 2.2.5 Suono Bio: Interview with Carl Schoellhammer -- 2.2.5.1 Core Technology -- 2.2.5.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.5.3 Why was it Important to Start Suono Bio? -- 2.2.5.4 When was the Technology Ready to Start Suono Bio? -- 2.2.5.5 What Lessons Did You Learn Through This Process? -- 2.2.5.6 Current Status -- 2.2.6 Vivtex: Interview with Thomas von Erlach -- 2.2.6.1 Core Technology -- 2.2.6.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.6.3 Why was it Important to Start Vivtex? -- 2.2.6.4 When was the Technology Ready to Vivtex? -- 2.2.6.5 What Lessons Did You Learn Through This Process? -- 2.2.6.6 Current Status -- 2.3 Why Start a Company? -- 2.3.1 To Have the Largest Impact on Patients -- 2.3.2 To Introduce a New Platform Technology -- 2.3.3 Is Licensing an Alternative? -- 2.3.3.1 Licensing to Existing Companies -- 2.3.3.2 Corporate‐sponsored Academic Research -- 2.4 When to Start a Company? -- 2.4.1 Is There Enough In Vivo Validation? -- 2.4.2 Was a Patent Filed? -- 2.4.3 Was a Paper Published? -- 2.5 The Secret Ingredient: Who and What? -- 2.5.1 Who Will Start the Company? -- 2.5.1.1 Seasoned Mentors as Co‐founders -- 2.5.1.2 Finding a Great CEO -- 2.5.2 What Will the Company Actually Sell? -- 2.6 Summary: Lessons Learned -- 2.6.1 Lesson 1: Work on a High‐impact, Platform Technology. 2.6.2 Lesson 2: Patent Early and Broadly -- 2.6.3 Lesson 3: Keep the Tech in the Lab as Long as Possible -- 2.6.4 Lesson 4: Must have in vivo Efficacy and Safety -- 2.6.5 Lesson 5: Publish in Top Scientific Journals -- 2.6.6 Lesson 6: Partner with Seasoned Entrepreneurs -- Further Reading -- Author Biographies -- Chapter 3 In Pursuit of New Product Opportunities: Transferring Technology from Lab to Market -- 3.1 Introduction -- 3.1.1 Entrepreneurship and Technology Transfer -- 3.1.2 Pursuing Commercial Product/Service Opportunities via Technology Transfer -- 3.1.3 A Model for Entrepreneurship via Technology Transfer -- 3.1.4 Extracting Technologies from Research Institutions -- 3.2 Technology Discovery and Development -- 3.2.1 Origins of Technology -- 3.2.2 Technology Transfer Communication Models -- 3.2.3 Transitioning Technologies into Products -- 3.2.4 Timing Technology with Industry Acceptance -- 3.3 Customer Discovery and Development -- 3.3.1 Origins of Market Demand and Unmet Needs -- 3.3.2 Identifying a Technology's Uses -- 3.3.3 The Value Chain for Target Applications -- 3.3.4 Identifying Stakeholders in the Value Chain -- 3.3.5 Designing Product Experiments -- 3.3.6 Customer Discovery and Validation Model -- 3.3.6.1 Customer Routines Analysis -- 3.4 Case Study: The Naval Research Laboratory's Self‐Decontaminating Material -- 3.4.1 The Challenge -- 3.4.2 The Scientist -- 3.4.3 The Problem -- 3.4.4 The Solution -- 3.4.5 The Future of the Technology and Future Applications -- 3.4.6 Technology Background and Advantages -- 3.4.7 Benefits -- 3.4.8 Problem -- 3.4.9 Technical Approach -- 3.4.10 Solution -- 3.4.11 Industrial Safety and Hygiene -- 3.4.12 Healthcare and Pharmaceuticals -- 3.4.13 First Response -- Suggested Reading and Resources -- Author Biography -- Chapter 4 Financing and Business Development for Hard Tech Startups. 4.1 Introduction -- 4.2 Challenges in Financing Hard Tech Startups -- 4.2.1 Balancing Ambition with Reality -- 4.2.2 Hard Tech Sure Is Not Software -- 4.2.3 Hard Tech Investors Are a Skeptical Bunch -- 4.2.4 What Do You Mean I Will Not Exit for 1B? -- 4.2.5 Hard Tech Fundraising Dissonance -- 4.3 Fundraising the Right Way -- 4.3.1 What Kind of Investors Should You Raise from? -- 4.3.1.1 Friends and Family -- 4.3.1.2 Angels -- 4.3.1.3 Early‐Stage Institutional Venture Capitalists -- 4.3.1.4 Late‐Stage Institutional Venture Capitalists -- 4.3.1.5 Corporate Venture Capital -- 4.3.2 Venture Capital Uncovered -- 4.3.2.1 Fund Life -- 4.3.2.2 Return the Fund -- 4.3.2.3 The Mythical 10× and Why It Is Important to You -- 4.3.3 How to Generate Interest from Investors? -- 4.3.3.1 Team -- 4.3.3.2 Differentiated Technology and Customer Value Proposition -- 4.3.3.3 Large Target Market -- 4.3.3.4 Compelling Plan to Build a Business -- 4.4 The Case for Early‐Stage Business Development -- 4.4.1.1 Playbook for Early‐Stage Business Development -- 4.4.1.2 Getting Started -- 4.4.1.3 Getting to the Finish Line -- 4.4.1.4 Avoiding Common Pitfalls -- 4.5 Summary -- Suggested Reading -- Author Biographies -- Chapter 5 Battery Entrepreneurship: Gameboard from Lab to Market -- 5.1 Introduction -- 5.2 Finding a Market Fit for Your Technology -- 5.3 Energy Storage Markets -- 5.3.1 Portable Electronics, Drones, and Medical Devices -- 5.3.2 Grid Energy Storage and Renewable Energy -- 5.3.3 Industrial Batteries and Back‐up Power -- 5.3.4 Home Energy Storage -- 5.3.5 Electric Vehicles -- 5.3.5.1 Passenger Cars -- 5.3.5.2 Light Electric Utility Vehicles -- 5.3.5.3 Heavy‐duty Utility Vehicles, Trucks, and Buses -- 5.3.6 Other Nascent Energy Storage Markets -- 5.3.7 Airplanes -- 5.3.8 Ships and Boats -- 5.4 Battery Startup Case Studies -- 5.4.1 Boston Power -- 5.4.2 A123 Systems. 5.4.3 Aquion Energy. |
Record Nr. | UNINA-9910554802703321 |
Weinheim, Germany : , : John Wiley & Sons, , [2022] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Chemistry entrepreneurship / / edited by Javier García-Martínez and Kunhao Li |
Pubbl/distr/stampa | Weinheim, Germany : , : John Wiley & Sons, , [2022] |
Descrizione fisica | 1 online resource (291 pages) |
Disciplina | 338.4766 |
Soggetto topico |
Chemical industry
Entrepreneurship Chemical workers |
ISBN |
3-527-81987-8
3-527-81986-X 3-527-81985-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover -- Title Page -- Copyright -- Contents -- Foreword -- Preface -- Chapter 1 We Need An Entrepreneurial Culture in Chemistry: Do You Have What It Takes to be a Chemistry Entrepreneur? -- 1.1 Introduction: Disruptive Innovation in Chemistry is in High Demand -- 1.2 Examples of Innovation in Chemistry Catching the Eye of the Mainstream Market -- 1.2.1 Food and Nutrition -- 1.2.1.1 Just (formerly Hampton Creek) -- 1.2.1.2 Impossible Foods -- 1.2.1.3 Perfect Day -- 1.2.1.4 Endless West (formerly Ava Winery) -- 1.2.2 Sustainable/Renewable Chemistry -- 1.2.2.1 Ginkgo Bioworks -- 1.2.2.2 Modern Meadow -- 1.2.2.3 Genomatica -- 1.2.2.4 Zymergen -- 1.2.3 Biotech/Pharma -- 1.2.3.1 Moderna Therapeutics -- 1.2.3.2 Unity Biotechnology -- 1.2.3.3 CRISPR Therapeutics, Intellia Therapeutics, and Editas Medicine -- 1.2.4 Diagnostics -- 1.2.4.1 23andme -- 1.2.4.2 Grail Diagnostics -- 1.2.4.3 Viome -- 1.2.5 Cautionary Tales -- 1.2.5.1 Theranos -- 1.2.5.2 Solazyme (TerraVia) -- 1.3 Unique Challenges for Chemistry Entrepreneurs -- 1.3.1 The Most Important Trait of Every Chemical Entrepreneur -- 1.3.2 Chemistry Accelerators, Incubators, and Academic Spin‐offs -- 1.3.3 Do Something, do Anything, even if it is Wrong -- 1.3.3.1 Penicillin -- 1.3.3.2 Post‐It -- 1.3.3.3 Saccharin -- 1.3.3.4 Teflon -- 1.3.3.5 Viagra -- 1.3.4 You have your Discovery -- now you need a Patent -- 1.3.4.1 Provisional Patent -- 1.3.4.2 Patent Application -- 1.3.4.3 Patent Prosecution -- 1.3.4.4 Structure of the Patent Claims -- 1.3.4.5 Patent Search and Prior Art -- 1.3.4.6 Publishing Before Patenting -- 1.3.4.7 PCT International Patent -- 1.3.4.8 Protectable Patent Value -- 1.3.4.9 Selecting the Wrong Lawyer for the Job -- 1.4 Invention is Only the Beginning of Creating a Company -- 1.4.1 Know your Role: Founding CEO vs. Founder vs. Inventor.
1.4.2 Raising Money: Acquiring the Right Money at the Right Time -- 1.4.2.1 Self‐funding -- 1.4.2.2 Friends and Family -- 1.4.2.3 Angel Investors -- 1.4.2.4 Accelerators and Incubators -- 1.4.2.5 Debt -- 1.4.2.6 Strategic Investment -- 1.4.2.7 Private Equity -- 1.4.2.8 Venture Capital -- 1.4.2.9 Investment Banks -- 1.4.3 Can you get the idea for Commercialization? -- 1.4.4 When you are Ready to Commercialize, which path do you take? -- 1.4.4.1 Licensing Deal -- 1.4.4.2 Business‐to‐Business (B2B) -- 1.4.4.3 Business‐to‐Consumer (B2C) -- 1.5 Do you have the Traits of an Entrepreneur? -- 1.6 Summary: Do You Have What It Takes? -- Recommended Readings and References -- Author Biography -- Chapter 2 Taking Ideas Out of the Lab: Why and When to Start a Company in the Biomedical Field -- 2.1 Introduction -- 2.2 Company Case Studies: Interviews with the Founding Scientists -- 2.2.1 Advanced Inhalation Research: Interview with David Edwards -- 2.2.1.1 Core Technology -- 2.2.1.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.1.3 Why was it Important to Start Advanced Inhalation Research? -- 2.2.1.4 When was the Technology Ready to Start Advanced Inhalation Research? -- 2.2.1.5 What Lessons Did You Learn Through This Process? -- 2.2.1.6 Current Status -- 2.2.2 Kala Pharmaceuticals: Interview with Justin Hanes -- 2.2.2.1 Core Technology -- 2.2.2.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.2.3 Why was it Important to Start Kala Pharmaceuticals? -- 2.2.2.4 When was the Technology Ready to Start Kala Pharmaceuticals? -- 2.2.2.5 What Lessons Did You Learn Through This Process? -- 2.2.2.6 Current Status -- 2.2.3 Moderna: Interview with Derrick Rossi -- 2.2.3.1 Core Technology -- 2.2.3.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.3.3 Why was it Important to Start Moderna?. 2.2.3.4 When was the Technology Ready to Start Moderna? -- 2.2.3.5 What Lessons Did You Learn Through This Process? -- 2.2.3.6 Current Status -- 2.2.4 Sigilon Therapeutics: Interview with Arturo Vegas -- 2.2.4.1 Core Technology -- 2.2.4.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.4.3 Why was it Important to Start Sigilon? -- 2.2.4.4 When was the Technology Ready to Start Sigilon? -- 2.2.4.5 What Lessons Did You Learn Through This Process? -- 2.2.4.6 Current Status -- 2.2.5 Suono Bio: Interview with Carl Schoellhammer -- 2.2.5.1 Core Technology -- 2.2.5.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.5.3 Why was it Important to Start Suono Bio? -- 2.2.5.4 When was the Technology Ready to Start Suono Bio? -- 2.2.5.5 What Lessons Did You Learn Through This Process? -- 2.2.5.6 Current Status -- 2.2.6 Vivtex: Interview with Thomas von Erlach -- 2.2.6.1 Core Technology -- 2.2.6.2 What was the Key Problem and Initial Idea that Sparked the Work? -- 2.2.6.3 Why was it Important to Start Vivtex? -- 2.2.6.4 When was the Technology Ready to Vivtex? -- 2.2.6.5 What Lessons Did You Learn Through This Process? -- 2.2.6.6 Current Status -- 2.3 Why Start a Company? -- 2.3.1 To Have the Largest Impact on Patients -- 2.3.2 To Introduce a New Platform Technology -- 2.3.3 Is Licensing an Alternative? -- 2.3.3.1 Licensing to Existing Companies -- 2.3.3.2 Corporate‐sponsored Academic Research -- 2.4 When to Start a Company? -- 2.4.1 Is There Enough In Vivo Validation? -- 2.4.2 Was a Patent Filed? -- 2.4.3 Was a Paper Published? -- 2.5 The Secret Ingredient: Who and What? -- 2.5.1 Who Will Start the Company? -- 2.5.1.1 Seasoned Mentors as Co‐founders -- 2.5.1.2 Finding a Great CEO -- 2.5.2 What Will the Company Actually Sell? -- 2.6 Summary: Lessons Learned -- 2.6.1 Lesson 1: Work on a High‐impact, Platform Technology. 2.6.2 Lesson 2: Patent Early and Broadly -- 2.6.3 Lesson 3: Keep the Tech in the Lab as Long as Possible -- 2.6.4 Lesson 4: Must have in vivo Efficacy and Safety -- 2.6.5 Lesson 5: Publish in Top Scientific Journals -- 2.6.6 Lesson 6: Partner with Seasoned Entrepreneurs -- Further Reading -- Author Biographies -- Chapter 3 In Pursuit of New Product Opportunities: Transferring Technology from Lab to Market -- 3.1 Introduction -- 3.1.1 Entrepreneurship and Technology Transfer -- 3.1.2 Pursuing Commercial Product/Service Opportunities via Technology Transfer -- 3.1.3 A Model for Entrepreneurship via Technology Transfer -- 3.1.4 Extracting Technologies from Research Institutions -- 3.2 Technology Discovery and Development -- 3.2.1 Origins of Technology -- 3.2.2 Technology Transfer Communication Models -- 3.2.3 Transitioning Technologies into Products -- 3.2.4 Timing Technology with Industry Acceptance -- 3.3 Customer Discovery and Development -- 3.3.1 Origins of Market Demand and Unmet Needs -- 3.3.2 Identifying a Technology's Uses -- 3.3.3 The Value Chain for Target Applications -- 3.3.4 Identifying Stakeholders in the Value Chain -- 3.3.5 Designing Product Experiments -- 3.3.6 Customer Discovery and Validation Model -- 3.3.6.1 Customer Routines Analysis -- 3.4 Case Study: The Naval Research Laboratory's Self‐Decontaminating Material -- 3.4.1 The Challenge -- 3.4.2 The Scientist -- 3.4.3 The Problem -- 3.4.4 The Solution -- 3.4.5 The Future of the Technology and Future Applications -- 3.4.6 Technology Background and Advantages -- 3.4.7 Benefits -- 3.4.8 Problem -- 3.4.9 Technical Approach -- 3.4.10 Solution -- 3.4.11 Industrial Safety and Hygiene -- 3.4.12 Healthcare and Pharmaceuticals -- 3.4.13 First Response -- Suggested Reading and Resources -- Author Biography -- Chapter 4 Financing and Business Development for Hard Tech Startups. 4.1 Introduction -- 4.2 Challenges in Financing Hard Tech Startups -- 4.2.1 Balancing Ambition with Reality -- 4.2.2 Hard Tech Sure Is Not Software -- 4.2.3 Hard Tech Investors Are a Skeptical Bunch -- 4.2.4 What Do You Mean I Will Not Exit for 1B? -- 4.2.5 Hard Tech Fundraising Dissonance -- 4.3 Fundraising the Right Way -- 4.3.1 What Kind of Investors Should You Raise from? -- 4.3.1.1 Friends and Family -- 4.3.1.2 Angels -- 4.3.1.3 Early‐Stage Institutional Venture Capitalists -- 4.3.1.4 Late‐Stage Institutional Venture Capitalists -- 4.3.1.5 Corporate Venture Capital -- 4.3.2 Venture Capital Uncovered -- 4.3.2.1 Fund Life -- 4.3.2.2 Return the Fund -- 4.3.2.3 The Mythical 10× and Why It Is Important to You -- 4.3.3 How to Generate Interest from Investors? -- 4.3.3.1 Team -- 4.3.3.2 Differentiated Technology and Customer Value Proposition -- 4.3.3.3 Large Target Market -- 4.3.3.4 Compelling Plan to Build a Business -- 4.4 The Case for Early‐Stage Business Development -- 4.4.1.1 Playbook for Early‐Stage Business Development -- 4.4.1.2 Getting Started -- 4.4.1.3 Getting to the Finish Line -- 4.4.1.4 Avoiding Common Pitfalls -- 4.5 Summary -- Suggested Reading -- Author Biographies -- Chapter 5 Battery Entrepreneurship: Gameboard from Lab to Market -- 5.1 Introduction -- 5.2 Finding a Market Fit for Your Technology -- 5.3 Energy Storage Markets -- 5.3.1 Portable Electronics, Drones, and Medical Devices -- 5.3.2 Grid Energy Storage and Renewable Energy -- 5.3.3 Industrial Batteries and Back‐up Power -- 5.3.4 Home Energy Storage -- 5.3.5 Electric Vehicles -- 5.3.5.1 Passenger Cars -- 5.3.5.2 Light Electric Utility Vehicles -- 5.3.5.3 Heavy‐duty Utility Vehicles, Trucks, and Buses -- 5.3.6 Other Nascent Energy Storage Markets -- 5.3.7 Airplanes -- 5.3.8 Ships and Boats -- 5.4 Battery Startup Case Studies -- 5.4.1 Boston Power -- 5.4.2 A123 Systems. 5.4.3 Aquion Energy. |
Record Nr. | UNINA-9910830498603321 |
Weinheim, Germany : , : John Wiley & Sons, , [2022] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
China's technology innovators [[electronic resource] ] : selected cases on creating and staying ahead of business trends / / by Xiaoming Zhu |
Autore | Zhu Xiaoming |
Edizione | [1st ed. 2018.] |
Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 |
Descrizione fisica | 1 online resource (XVI, 180 p. 30 illus., 18 illus. in color.) |
Disciplina | 338.0640951 |
Collana | Management for Professionals |
Soggetto topico |
Management
Industrial management Entrepreneurship Innovation/Technology Management |
ISBN | 981-10-5388-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Case I 3DMed: A Platform for R&D of Pharmaceuticals for Precision Cancer Care -- Case II Micro Platform, Great Innovation: Innovation Ecosystem Shaped by WeChat -- Case III SHANGHAI GM: The Way to Intelligent Manufacturing -- Case IV Can Robots Raise Laying Hens? -- Case V Alibaba: A Decade-long Road to Financial Services -- Case VI Changing with the Times: AutoNavi’s Autonomous Development -- Case VII ICBC in the Digital Age. |
Record Nr. | UNINA-9910298187003321 |
Zhu Xiaoming
![]() |
||
Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Chinese Global Production Networks in ASEAN / / edited by Young-Chan Kim |
Edizione | [1st ed. 2016.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
Descrizione fisica | 1 online resource (289 p.) |
Disciplina | 330.95 |
Collana | Understanding China |
Soggetto topico |
International economics
International business enterprises Entrepreneurship Political economy Economic sociology Development economics International Economics International Business International Political Economy Organizational Studies, Economic Sociology Development Economics |
ISBN | 3-319-24232-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1.Introduction: Emerging China and Its Impact on ASEAN Economies -- 2.The RCEP vs. TPP - The pursuit of Eastern Dominance -- 3.The Malaysia-China Economic Relationship at 40: Broadening Ties and Meeting the Challenges for Future Success -- 4.Indonesia-China Economic Relations in the 21st Century: Opportunities and Challenges -- 5.People’s Republic of China – Thailand economic relationship after signing of free trade agreement in 2005 -- 6.Is urban food demand in the Philippines different from China? -- 7.Greater China, Cambodia, and the Garment Industry -- 8.Politics of Economic Relations between China and Myanmar -- 9.A Study of Singapore as a Developmental State -- 10.Vietnam – China economic relations and recommendations for ASEAN – China cooperation -- 11.Tai-shang (Taiwan business) in Southeast Asia: Profile and Issues -- 12.India and China: ‘Awakening Giants’ Towards a Win-Win Future? -- 13.Conclusion: Economic Cooperation and the regional production cluster. |
Record Nr. | UNINA-9910254871303321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Christian Ethics and Corporate Culture : A Critical View on Corporate Responsibilities / / edited by Bartholomew Okonkwo |
Edizione | [1st ed. 2014.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2014 |
Descrizione fisica | xii, 194 p |
Disciplina | 174.4 |
Collana | CSR, Sustainability, Ethics & Governance |
Soggetto topico |
Business ethics
Entrepreneurship Organization Planning Personnel management Religion Ethics Business Ethics Human Resource Management Religious Studies, general |
ISBN | 3-319-00939-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Seeing the World of Business -- The Business in Society: Can Companies Save the World -- Philosophical Underpinnings of Good Company -- The Challenge of Clashing Theories -- Social Vocation of the Firm -- Non Profit and Business Sector Collaboration -- The Common Good and Social Competitive Creativity -- Maximizing the Shareholder Value -- Consumer, Client, Customer or Citizen - Can the State be a Good Company -- Doing Well by Doing Good: Distinguishing the Right from Good in Theories of Corporate Social Responsibility -- Moral Intuition and Transformative Organizations -- The Game of Exchange: Towards Justice in Bargaining -- The Posture of Services -- When Being Good Isn't Good Enough: the Case of Malden Mills -- What of Financialization? -- Accounting for Just Wages: A Proposal -- A Framework for CSR Assessment, Measurement and Reporting. |
Record Nr. | UNINA-9910298541603321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cisco [[electronic resource] ] : Integration of Innovation and Operation / / by Xiaoying Dong, Yan Yu, Jiali Zhou |
Autore | Dong Xiaoying |
Edizione | [1st ed. 2023.] |
Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
Descrizione fisica | 1 online resource (229 pages) |
Disciplina | 658.054678 |
Soggetto topico |
Entrepreneurship
New business enterprises Management Business information services IT in Business |
ISBN | 981-19-7870-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1 Integration of innovation and operation: The way multinational companies survive -- Chapter 2 Strategic leadership -- Chapter 3 Enterprise transformation and change management -- Chapter 4 Innovation system -- Chapter 5 M&A strategy and management -- Chapter 6 Strategic alliance and Partnership management -- Chapter 7 Build highly adaptable corporate culture -- Chapter 8 Corporate Governance and Risk Management -- Chapter 9 Informatization and value chain management -- Chapter 10 Collaborative organization and knowledge management -- Appendix. |
Record Nr. | UNINA-9910645891203321 |
Dong Xiaoying
![]() |
||
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The Co-creative Meeting [[electronic resource] ] : Practicing Consensual Effectivity in Organizations / / by Christoph Mandl, Markus Hauser, Hanna Mandl |
Autore | Mandl Christoph |
Edizione | [1st ed. 2013.] |
Pubbl/distr/stampa | Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2013 |
Descrizione fisica | 1 online resource (110 p.) |
Disciplina | 720.92 |
Collana | SpringerBriefs in Business |
Soggetto topico |
Leadership
Management Industrial management Entrepreneurship Business ethics Business Strategy/Leadership Innovation/Technology Management Business Ethics |
ISBN |
1-283-93536-8
3-642-34231-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Foreword -- 1 Introduction -- 2 What is a Co-creative Meeting? -- 3 Dysfunctional Meeting Culture -- 4 Interdependency of Meetings and Organizations -- 5 Maxims of the Co-creative Meeting -- 6 Phases and Roles -- 7 Designing for Co-creativity -- 8 Institutionalizing Co-creative Meetings -- 9 Structural Variations for Co-creative Meetings -- 10 Consensual Efficiency -- Index. |
Record Nr. | UNINA-9910438082503321 |
Mandl Christoph
![]() |
||
Berlin, Heidelberg : , : Springer Berlin Heidelberg : , : Imprint : Springer, , 2013 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Co-evolution strategy canvas / / Jiang Yong Lu |
Autore | Lu Jiang Yong |
Edizione | [1st ed. 2021.] |
Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (X, 227 p. 213 illus., 41 illus. in color.) |
Disciplina | 658.421 |
Soggetto topico | Entrepreneurship |
ISBN | 981-15-5988-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. Co-evolution -- Chapter 2. Elements -- Chapter 3. Phases -- Chapter 4. Start-up -- Chapter 5. Growing-up -- Chapter 6. Expansion -- Chapter 7. Transformation -- Chapter 8. Systematicness -- Chapter 9. Dynamics -- Chapter 10. Appendix. |
Record Nr. | UNINA-9910483549803321 |
Lu Jiang Yong
![]() |
||
Gateway East, Singapore : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Co-Innovation Competence : A Strategic Approach to Entrepreneurship in Regional Innovation Structures / / by Benedict C. Doepfer |
Autore | Doepfer Benedict C |
Edizione | [1st ed. 2013.] |
Pubbl/distr/stampa | Wiesbaden : , : Springer Fachmedien Wiesbaden : , : Imprint : Springer Gabler, , 2013 |
Descrizione fisica | 1 online resource (288 p.) |
Disciplina | 658.421 |
Collana | Entrepreneurial Management und Standortentwicklung, Perspektiven für Unternehmen und Destinationen |
Soggetto topico | Entrepreneurship |
ISBN |
1-283-93553-8
3-658-00255-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Open-Innovation -- Regional Innovation Systems -- Entrepreneurial Networks -- Social Capital Promotors. |
Record Nr. | UNINA-9910438093303321 |
Doepfer Benedict C
![]() |
||
Wiesbaden : , : Springer Fachmedien Wiesbaden : , : Imprint : Springer Gabler, , 2013 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|